Glaukos Inventory 2014-2024 | GKOS
Glaukos inventory from 2014 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
- Glaukos inventory for the quarter ending December 31, 2024 was $0.058B, a 37.37% increase year-over-year.
- Glaukos inventory for 2024 was $0.058B, a 37.37% increase from 2023.
- Glaukos inventory for 2023 was $0.042B, a 10.95% increase from 2022.
- Glaukos inventory for 2022 was $0.038B, a 64.45% increase from 2021.
| Glaukos Annual Inventory (Millions of US $) |
|
|---|---|
| 2024 | $58 |
| 2023 | $42 |
| 2022 | $38 |
| 2021 | $23 |
| 2020 | $16 |
| 2019 | $43 |
| 2018 | $13 |
| 2017 | $11 |
| 2016 | $7 |
| 2015 | $4 |
| 2014 | $2 |
| 2013 | $2 |
| Glaukos Quarterly Inventory (Millions of US $) |
|
|---|---|
| 2024-12-31 | $58 |
| 2024-09-30 | $60 |
| 2024-06-30 | $56 |
| 2024-03-31 | $50 |
| 2023-12-31 | $42 |
| 2023-09-30 | $40 |
| 2023-06-30 | $39 |
| 2023-03-31 | $40 |
| 2022-12-31 | $38 |
| 2022-09-30 | $34 |
| 2022-06-30 | $28 |
| 2022-03-31 | $25 |
| 2021-12-31 | $23 |
| 2021-09-30 | $20 |
| 2021-06-30 | $18 |
| 2021-03-31 | $15 |
| 2020-12-31 | $16 |
| 2020-09-30 | $20 |
| 2020-06-30 | $21 |
| 2020-03-31 | $28 |
| 2019-12-31 | $43 |
| 2019-09-30 | $13 |
| 2019-06-30 | $14 |
| 2019-03-31 | $13 |
| 2018-12-31 | $13 |
| 2018-09-30 | $14 |
| 2018-06-30 | $14 |
| 2018-03-31 | $13 |
| 2017-12-31 | $11 |
| 2017-09-30 | $9 |
| 2017-06-30 | $8 |
| 2017-03-31 | $7 |
| 2016-12-31 | $7 |
| 2016-09-30 | $6 |
| 2016-06-30 | $6 |
| 2016-03-31 | $5 |
| 2015-12-31 | $4 |
| 2015-09-30 | $3 |
| 2015-06-30 | $3 |
| 2015-03-31 | $3 |
| 2014-12-31 | $2 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.042B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.166B | 84.17 |
| Thermo Fisher Scientific (TMO) | United States | $153.961B | 18.62 |
| Alcon (ALC) | Switzerland | $47.401B | 31.51 |
| Edwards Lifesciences (EW) | United States | $44.018B | 28.86 |
| IDEXX Laboratories (IDXX) | United States | $39.134B | 44.97 |
| DexCom (DXCM) | United States | $32.682B | 50.51 |
| IQVIA Holdings (IQV) | United States | $26.521B | 14.85 |
| Mettler-Toledo (MTD) | United States | $22.538B | 26.80 |
| STERIS (STE) | Ireland | $22.108B | 25.28 |
| Waters (WAT) | United States | $20.558B | 29.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.317B | 0.00 |
| Hologic (HOLX) | United States | $12.352B | 13.42 |
| Sysmex ADR (SSMXY) | Japan | $11.507B | 0.00 |
| Penumbra (PEN) | United States | $11.201B | 87.92 |
| Globus Medical (GMED) | United States | $9.836B | 22.77 |
| Masimo (MASI) | United States | $8.139B | 30.02 |
| Teleflex (TFX) | United States | $5.395B | 8.90 |
| Integer Holdings (ITGR) | United States | $4.151B | 21.75 |
| TransMedics (TMDX) | United States | $3.241B | 94.86 |
| PROCEPT BioRobotics (PRCT) | United States | $2.939B | 0.00 |
| Veracyte (VCYT) | United States | $2.415B | 33.89 |
| LivaNova (LIVN) | United Kingdom | $2.372B | 14.12 |
| Nihon Kohden (NHNKY) | Japan | $2.127B | 11.63 |
| Elekta AB (EKTAY) | Sweden | $1.860B | 16.72 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.483B | 0.00 |
| Artivion (AORT) | United States | $1.212B | 113.52 |
| Pulse Biosciences (PLSE) | United States | $1.123B | 0.00 |
| OPKO Health (OPK) | United States | $0.991B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.989B | 5.26 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.744B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.654B | 14.29 |
| IRadimed (IRMD) | United States | $0.649B | 32.91 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| RxSight (RXST) | United States | $0.605B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.582B | 9.05 |
| OrthoPediatrics (KIDS) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.469B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.453B | 0.00 |
| NeuroPace (NPCE) | United States | $0.397B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.388B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.372B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.356B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.317B | 6.73 |
| Neuronetics (STIM) | United States | $0.300B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.224B | 13.58 |
| CVRx (CVRX) | United States | $0.195B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.163B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.148B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.087B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.070B | 10.55 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.29 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.14 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |